Topical 5-aminosalicylate can be added to high dose (4 g) oral therapy without significant changes to urinary concentrations of 5-aminosalicylate and acetyl-5-aminosalicylate or evidence of renal adverse effects

被引：0

|

作者：

Probert, C ^{[1
]}

Marteau, P ^{[1
]}

Ford, J ^{[1
]}

Rademaker, J ^{[1
]}

Parkes, M ^{[1
]}

Forbes, A ^{[1
]}

Riley, S ^{[1
]}

Burke, D ^{[1
]}

Tham, TCK ^{[1
]}

Foldager, M ^{[1
]}

机构：

[1] Bristol Royal Infirm & Gen Hosp, Bristol, Avon, England

来源：

GUT | 2005年 / 54卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

356

引用

收藏

页码：A93 / A94

页数：2

相关论文

共 3 条

[1] Efficacy of topical versus oral 5-aminosalicylate for treatment of 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats
Li, Jin
Chen, Cheng
Cao, Xiao-nian
Wang, Gui-hua
Hu, Jun-bo
Wang, Jing
JOURNAL OF HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY-MEDICAL SCIENCES, 2014, 34 (01) : 59 - 65
[2] Efficacy of topical versus oral 5-aminosalicylate for treatment of 2,4,6-trinitrobenzene sulfonic acid-induced ulcerative colitis in rats
Jin Li
Cheng Chen
Xiao-nian Cao
Gui-hua Wang
Jun-bo Hu
Jing Wang
Journal of Huazhong University of Science and Technology [Medical Sciences], 2014, 34 : 59 - 65
[3] Efficacy of Topical versus Oral 5-Aminosalicylate for Treatment of 2,4,6-Trinitrobenzene Sulfonic Acid-induced Ulcerative Colitis in Rats
李进
陈成
曹小年
王桂华
胡俊波
王晶
Current Medical Science, 2014, (01) : 59 - 65